APA (7th ed.) Citation

Pearse, R. N. (2020). Sequence matters: Elotuzumab more effective if used before daratumumab. Leukemia & Lymphoma, 61(3), 507. https://doi.org/10.1080/10428194.2019.1703972

Chicago Style (17th ed.) Citation

Pearse, Roger N. "Sequence Matters: Elotuzumab More Effective If Used Before Daratumumab." Leukemia & Lymphoma 61, no. 3 (2020): 507. https://doi.org/10.1080/10428194.2019.1703972.

MLA (9th ed.) Citation

Pearse, Roger N. "Sequence Matters: Elotuzumab More Effective If Used Before Daratumumab." Leukemia & Lymphoma, vol. 61, no. 3, 2020, p. 507, https://doi.org/10.1080/10428194.2019.1703972.